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A Corrigendum on
Use of UV Treated Milk Powder to Increase Vaccine Efficacy in the Elderly
by Schaefer, S., Hettinga, K. A., Cullor, J., German, J. B., and Henrick, B. M. (2018). Front. Immunol.
9:2254. doi: 10.3389/fimmu.2018.02254
In the original article, there was an error. The vaccine used in the trial is listed as Boostrix R© (Merck
Research Laboratory, Whitehouse Station, USA). The correct source of the DTaP vaccine used in
this study is “Adacel R© not “Boostrix R©.”
A correction has been made to theMaterials and Methods,Human Samples:
“Peripheral blood samples were collected at the time of enrollment (week 0) and serum was
stored at −80◦C until subsequent analysis. Participants were then randomized into two groups
and provided with equal concentration and quantity of either dairy or soy supplement provided
in powdered form in coded, single-serving bags. Both participants and researchers were blinded to
the type of protein received. Participants were asked to consume two servings of protein powder
(6 grams/packet) with 4 ounces of water or applesauce twice per day, with meals, for a total of 8
weeks. At week 4, participants were vaccinated with DTaP vaccine (Sanofi Pasteur Inc., Swiftwater
PA). A 0.5-mL dose of Adacel R© is formulated to contain 5 Lf of tetanus toxoid, 2.5 Lf of diphtheria
toxoid, 8µg of inactivated PT, 8µg of FHA, and 2.5µg of pertactin (69 kiloDalton outer membrane
protein). Each 0.5-mL dose contains aluminum hydroxide as adjuvant (not more than 0.39mg
aluminum by assay), 4.5mg of sodium chloride,≤ 100 µg of residual formaldehyde, and≤ 100 µg
of polysorbate 80 (Tween 80). A second blood draw was obtained 4 weeks after vaccination (week
8) and serum collected for DTaP antibody analysis. The design and participant progression through
the study is presented in Figure 1.”
The authors apologize for this error and state that this does not change the scientific conclusions
of the article in any way. The original article has been updated.
Copyright © 2019 Schaefer, Hettinga, Cullor, German and Henrick. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with
these terms.
